These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

83 related articles for article (PubMed ID: 554876)

  • 1. [Electrophysiological study of the neurotoxicity of middle molecules].
    Bernard PJ; Rinaudo JB; Crevat A; Gallice P; Fournier N; Murisasco A; Saingra S; Frayssinet R; Henry JF
    J Urol Nephrol (Paris); 1979 Dec; 85(12):883-7. PubMed ID: 554876
    [No Abstract]   [Full Text] [Related]  

  • 2. [Diagnostic value of determining middle molecules in the blood plasma in nephrological diseases].
    Gabriélian NI; Dmitriev AA; Kulakov GP; Melikian AM; Shcherbaneva OI
    Klin Med (Mosk); 1981 Oct; 59(10):38-42. PubMed ID: 7311409
    [No Abstract]   [Full Text] [Related]  

  • 3. Blood levels of middle molecules and their effects on motor nerve conduction velocity.
    Botella J; Gea T; Sanz-Guajardo D; Criado M; Torres MT; Guardiola J
    Artif Organs; 1981; 4 Suppl():151-5. PubMed ID: 7295082
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Uremia toxins: effect of medium and high molecular fractions from normal urine on gluconeogenesis of the kidney cortex sections in the rat].
    Lamberts B; Brunner H; Heintz R
    Verh Dtsch Ges Inn Med; 1974; 80():722-5. PubMed ID: 4454647
    [No Abstract]   [Full Text] [Related]  

  • 5. ["The middle molecules" are uremic toxins (author's transl)].
    Hanicki Z; Cichocki T
    Przegl Lek; 1978; 35(2):301-5. PubMed ID: 652997
    [No Abstract]   [Full Text] [Related]  

  • 6. Neurotoxicity of parathyroid hormone in uremia.
    Massry SG
    Kidney Int Suppl; 1985 Dec; 17():S5-11. PubMed ID: 3912589
    [No Abstract]   [Full Text] [Related]  

  • 7. Proceedings of the meetings of the Environmental Neurology Club, Paris, France, 2-3 December 2005 and Metz, France, 7 February 2007.
    J Neurol Sci; 2007 Nov; 262(1-2):1-170. PubMed ID: 18087770
    [No Abstract]   [Full Text] [Related]  

  • 8. The neurology of enteric disease.
    Wills AJ; Pengiran Tengah DS; Holmes GK
    J Neurol Neurosurg Psychiatry; 2006 Jul; 77(7):805-10. PubMed ID: 16574728
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Middle molecules. Myth or reality?
    Hanicki Z
    Mater Med Pol; 1985; 17(1):51-5. PubMed ID: 4033225
    [No Abstract]   [Full Text] [Related]  

  • 10. Middle molecules in hepatic coma and uremia.
    Chang TM; Lister C
    Artif Organs; 1981; 4 Suppl():169-72. PubMed ID: 7295086
    [No Abstract]   [Full Text] [Related]  

  • 11. [Pathogenesis of neurologic disorders during kidney failure].
    Korchemnyĭ VA
    Vrach Delo; 1977 Feb; (2):81-4. PubMed ID: 860471
    [No Abstract]   [Full Text] [Related]  

  • 12. Serum middle molecules in uremia.
    Buzio C; Manari A; Calderini C; Montagna G; Migone L
    Artif Organs; 1981; 4 Suppl():143-50. PubMed ID: 7295081
    [No Abstract]   [Full Text] [Related]  

  • 13. Characterization of a 1100-1300 MW uremic neurotoxin.
    Funck-Brentano JL; Man NK; Sausse A; Zingraff J; Boudet J; Becker A; Cueille GF
    Trans Am Soc Artif Intern Organs; 1976; 22():163-7. PubMed ID: 951836
    [No Abstract]   [Full Text] [Related]  

  • 14. [Regression of uremia-induced suppression of erythropoiesis in patients with chronic kidney disease].
    Uhl N; Rehn K
    Verh Dtsch Ges Inn Med; 1974; 80():755-7. PubMed ID: 4454655
    [No Abstract]   [Full Text] [Related]  

  • 15. "Middle molecules" in acute experimental uremia.
    Lutz W; Madry K; Grande G
    Acta Med Pol; 1978; 19(4):417-24. PubMed ID: 752244
    [No Abstract]   [Full Text] [Related]  

  • 16. [A comparison of the efficiency of eliminating middle-weight molecules and myoinositol from plasma during hemoperfusion and hemodialysis in cases of chronic uremia].
    Trznadel K; Kidawa Z; Walasek L; Lutz W
    Pol Tyg Lek; 1978 Feb; 33(7):257-9. PubMed ID: 758030
    [No Abstract]   [Full Text] [Related]  

  • 17. [Middle molecules and the problem of endogenous intoxication in critical states of various etiologies].
    Vladyka AS; Levitskiĭ ER; Poddubnaia LP; Gabriélian NI
    Anesteziol Reanimatol; 1987; (2):37-42. PubMed ID: 3300433
    [No Abstract]   [Full Text] [Related]  

  • 18. [Effect of "uremia toxins" on exocrine secretion of the isolated pancreas].
    Wizemann V; Klewer H; Wiesenecker C; Schütterle G
    Verh Dtsch Ges Inn Med; 1974; 80():718-20. PubMed ID: 4454644
    [No Abstract]   [Full Text] [Related]  

  • 19. [Use of the determination of the blood serum levels of middle molecules for screening azotemia].
    Titel'man KM; Mustafaeva TM; Ianovskaia IK
    Lab Delo; 1986; (3):143-5. PubMed ID: 2421080
    [No Abstract]   [Full Text] [Related]  

  • 20. Separation and characterization of uremic metabolites in biologic fluids: a screening approach to the definition of uremic toxins.
    Gordon A; Berström J; Fürst P; Zimmerman L
    Kidney Int Suppl; 1975 Jan; (2):45-51. PubMed ID: 1057692
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.